Suchergebnisse - "McGonagle, Dennis"

PubPharm (11)

1

Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia : exploring the subclinical psoriatic arthritis stage

enthalten in: RMD open | 2024

von Zabotti, A. | Fagni, F. | Gossec, L. | +15

2

High prevalence of radiographic erosions in early, untreated PsA : results from the SpARRO cohort

enthalten in: RMD open | 2024

von Hen, O. | Di Matteo, A. | Dubash, S. | +7

3

Anti-IL-5 biologics and rheumatoid arthritis : a single-centre 500 patient year exposure analysis

enthalten in: RMD open | 2023

von Dean, N. | Clifton, I. | Salman, R. | +4

4

Characterisation of prodromal and very early psoriatic arthritis : a systematic literature review informing a EULAR taskforce

enthalten in: RMD open | 2023

von De Marco, G. | Zabotti, A. | Baraliakos, X. | +7

5

Immunomodulatory therapies for the treatment of SARS-CoV-2 infection : an update of the systematic literature review to inform EULAR points to consider

enthalten in: RMD open | 2021

von Alunno, A. | Najm, A. | Mariette, X. | +5

6

Pathophysiology of acute respiratory syndrome coronavirus 2 infection : a systematic literature review to inform EULAR points to consider

enthalten in: RMD open | 2021

von Najm, A. | Alunno, A. | Mariette, X. | +6

7

Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis : results from a randomised, placebo-controlled, phase II study

enthalten in: RMD open | 2020

von Mease, P. | Gladman, D. | Deodhar, A. | +9

8

Mixed results with baricitinib in biological-resistant adult-onset Still's disease and undifferentiated systemic autoinflammatory disease

enthalten in: RMD open | 2020

von Kacar, M. | Fitton, J. | Gough, A. | +3

9

Transition phase towards psoriatic arthritis : clinical and ultrasonographic characterisation of psoriatic arthralgia

enthalten in: RMD open | 2019

von Zabotti, A. | McGonagle, D. | Giovannini, I. | +13

10

MRI of psoriatic nail disease pre- and post-TNF inhibitor therapy shows persistent subclinical inflammation after 6 months despite good clinical response

enthalten in: RMD open | 2018

von Ash, Z. | Tan, A. | Hodgson, R. | +3